Skip to main content
Log in

Managing BRCA Mutation Carriers in China

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kwong A, Wong CH, Shea C et al (2010) Choice of management of southern Chinese BRCA mutation carriers. World J Surg 34:1416–1426

    Article  PubMed  Google Scholar 

  2. Ziogas D, Roukos DH (2009) Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice. Ann Surg Oncol 16:1771–1782

    Article  PubMed  Google Scholar 

  3. Metcalfe KA, Lubinski J, Ghadirian P et al (2008) Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. J Clin Oncol 26:1093–1097

    Article  PubMed  Google Scholar 

  4. Roukos DH (2009) Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology. Ann Surg 249(6):1067–1068

    Article  PubMed  Google Scholar 

  5. Roukos DH, Ziogas D (2010) From tumor size and HER2 status to systems oncology for very early breast cancer treatment. Expert Rev Anticancer Ther 10(2):123–128

    Article  CAS  PubMed  Google Scholar 

  6. Roukos DH, Ziogas DE, Katsios C (2010) Multigene assays and isolated tumor cells for early breast cancer treatment: time for bionetworks. Expert Rev Anticancer Ther 10(8):1187–1195

    Article  CAS  PubMed  Google Scholar 

  7. Roukos DH (2010) Complete genome sequencing and network modeling to overcome trastuzumab resistance. Pharmacogenomics 11(8):1039–1043

    Article  CAS  PubMed  Google Scholar 

  8. Roukos DH (2010) Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice. Biomark Med 4(4):583–586

    Article  PubMed  Google Scholar 

  9. Katsios C, Roukos DH (2010) Individual genomes and personalized medicine: life diversity and complexity. Per Med 7(4): 347–350

    Article  CAS  Google Scholar 

  10. Roukos DH, Katsios C, Liakakos T (2010) Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment. Expert Rev Mol Diagn 10(5):541–545

    Article  CAS  PubMed  Google Scholar 

  11. Roukos DH (2009) Radiation therapy for breast cancer. N Engl J Med 360(13):1362; author reply 1363

    Article  CAS  PubMed  Google Scholar 

  12. Roukos DH (2010) Systems medicine: a real approach for future personalized oncology? Pharmacogenomics 11(3):283–287

    Article  PubMed  Google Scholar 

  13. Roukos DH (2010) Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care. Expert Rev Mol Diagn 10(1):33–48

    Article  CAS  PubMed  Google Scholar 

  14. Roukos DH (2009) Isolated tumor cells in breast cancer. N Engl J Med 361:1994–1995; author reply 1995–1996

    Article  CAS  PubMed  Google Scholar 

  15. Roukos DH, Tzakos A, Zografos G (2009) Current concerns and challenges towards tailored anti-angiogenic therapy in cancer. Expert Rev Anticancer Ther 9(10):1413–1416

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kyriakos Kalogerakos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kalogerakos, K. Managing BRCA Mutation Carriers in China. World J Surg 35, 458–459 (2011). https://doi.org/10.1007/s00268-010-0788-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-010-0788-6

Keywords

Navigation